At 11.3% CAGR, the Europe Brain Health Supplements Market is Projected to be Worth US$ 3,434.14 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Europe brain health supplements market was valued at US$ 1,807.04 million in 2022 and is expected to reach US$ 3,434.14 million by 2028, registering a CAGR of 11.3% from 2022 to 2028. Growing prevalence of major depressive disorders and increasing demand for brain supplements among elderly population are the critical factors attributed to the Europe brain health supplements market expansion.

Leading companies in the brain health supplements market are focused on increasing their penetration across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. This can be attributed to the availability of a large patient pool with the growing elderly population; high prevalence of depression, anxiety, mood swings, and other mental and cognitive disorders; increasing levels of disposable income; and improving infrastructure in the healthcare sector.

Moreover, with maturing markets in the European countries, most players focus prefer to expand their presence in emerging countries. Further, high investments by governments in these countries in life science and health research favor the upgrading of facilities with the latest technologies. This is also driving the brain health supplements market players toward developing regions.  

On the contrary, lack of regulations and false claims by manufacturers hurdles the growth of Europe brain health supplements market.

Based on product, the Europe brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held 44.8% share of Europe brain health supplements market in 2022, amassing US$ 808.78 million. It is projected to garner US$ 1,509.50 million by 2028 to expand at 11.0% CAGR during 2022–2028. The natural molecules is further subsegmented into acetyl-L-carnitine, docosahexaenoic Acid (DHA), alpha GPC, citicoline, huperzine-A, and others. The herbal extract is further subsegmented into bacopa monnieri, ginkgo biloba, ginseng, curcumin, lion's mane, and others. The vitamins and minerals is further subsegmented into vitamins C and E, vitamin B complex and others.

Based on application, the Europe brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held 32.1% share of Europe brain health supplements market in 2022, amassing US$ 580.25 million. It is projected to garner US$ 1,120.80 million by 2028 to expand at 11.6% CAGR during 2022–2028.  

Based on dosage form, the Europe brain health supplements market is segmented into capsules, tablets, and others. The others segment held 47.2% share of Europe brain health supplements market in 2022, amassing US$ 852.33 million. It is projected to garner US$ 1,662.29 million by 2028 to expand at 11.8% CAGR during 2022–2028.

Based on distribution channel, the Europe brain health supplements market is segmented into supermarket and hypermarket, drug store, online and others. The supermarket and hypermarket segment held 40.5% share of Europe brain health supplements market in 2022, amassing US$ 731.78 million. It is projected to garner US$ 1,407.44 million by 2028 to expand at 11.5% CAGR during 2022–2028.

Based on age category, the Europe brain health supplements market is segmented into adults, children, and elderly. The adults segment held 50.4% share of Europe brain health supplements market in 2022, amassing US$ 910.16 million. It is projected to garner US$ 1,775.77 million by 2028 to expand at 11.8% CAGR during 2022–2028.

Based on country, the Europe brain health supplements market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 27.9% share of Europe brain health supplements market in 2022. It was assessed at US$ 456.60 million in 2022 and is likely to hit US$ 969.34 million by 2028, exhibiting a CAGR of 11.5% during 2022–2028.      

Key players operating in the Europe brain health supplements market are Intelligent Labs, Mind Lab Pro, Reckitt Benckiser Group Plc, and ReMind Brain Health Supplements, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com